Stent

SES with biodegradable polymer (Orsiro, Biotronik) vs. EES with durable polymer (Xience Xpedition/Alpine, Abbott Vascular) for PCI in patients with STEMI.

A biodegradable polymer sirolimus-eluting stent remained superior to a durable polymer everolimus-eluting stent at 2 years, researchers reported.

Medtronic announced a global voluntary recall of unused thoracic stent graft systems and notified physicians to immediately cease use until further notice.

Outcomes with 14 days of dual antiplatelet therapy after PCI with a nanocoated stent (Cobra PzF, CeloNova Biosciences) compared with 3- to 6-month DAPT after PCI with a drug-eluting stent.

Cook Medical announced its self-expanding venous stent received FDA premarket approval and is expected to be commercially available in the U.S. in the fourth quarter of 2020.

Medtronic announced it received FDA approval for its venous self-expanding stent system, indicated for use in the iliofemoral veins in patients with symptomatic iliofemoral venous outflow obstruction.

Among patients on oral anticoagulation, those who had dual antiplatelet therapy for 14 days after PCI with a nanocoated stent had worse outcomes compared with those assigned 3-to-6-month DAPT after PCI with a drug-eluting stent.

Boston Scientific announced that its bioabsorbable polymer stent platform has received a new indication from the FDA to treat patients at high bleeding risk.

Fully covered self-expandable metal stents were safe and effective for treating main pancreatic duct strictures linked to symptomatic chronic pancreatitis, according to a study published in the Journal of Gastroenterology and Hepatology.

Among patients with venous outflow obstruction, a self-expanding venous stent system was safe and effective, researchers reported at the virtual Charing Cross Symposium.